NestLens
Portfolio Company

Recode TX

Overview

ReCode is the first genetic medicines platform to enable highly targeted delivery to organs, tissues and cells beyond the liver. Our pipeline of rare disease therapeutics uses optimized mRNA and gene correction with redosing capability.

Visit website ↗View full profile on NestLens →

Related on NestLens

Last updated July 15, 2026